Regulatory & Compliance

Biogen Lupus Drug Earns FDA Breakthrough Designation
Management & Regulatory Biogen Lupus Drug Earns FDA Breakthrough Designation

For individuals grappling with the relentless and often disfiguring effects of cutaneous lupus erythematosus, the path to effective treatment has been long and fraught with limited options, but a significant development from Biogen offers a new beacon of hope. The U.S. Food and Drug Administration

Can Equitable Care Build a Healthier Future?
Management & Regulatory Can Equitable Care Build a Healthier Future?

In a world grappling with the compounding pressures of global conflict and environmental disasters, the very foundation of public health is being tested, revealing deep-seated inequities that threaten our collective future. The challenge is no longer merely about treating disease but about

Vendor Breach Exposes Jupiter Medical Patient Records
Management & Regulatory Vendor Breach Exposes Jupiter Medical Patient Records

The intricate web of modern healthcare technology, designed to streamline patient care, has once again demonstrated its potential vulnerability after a significant data breach at a third-party vendor exposed the sensitive records of patients from Jupiter Medical Center. The incident, which did not

Medical Tourism Takes a Hidden Financial Toll on the NHS
Research & Development Medical Tourism Takes a Hidden Financial Toll on the NHS

The allure of a cut-price cosmetic procedure or weight-loss surgery abroad often masks a harsh reality, one where complications can leave UK patients facing a health crisis and the National Health Service footing a bill that can spiral into tens of thousands of pounds. This growing trend of

Review of Wegovy 7.2mg Dose
Management & Regulatory Review of Wegovy 7.2mg Dose

For many individuals on a weight management journey, hitting a plateau can feel like an insurmountable barrier, but a new, higher dosage of a well-known medication aims to break through that very wall. This review assesses the clinical significance and therapeutic value of the newly approved 7.2mg

Review of Nucala for COPD
Management & Regulatory Review of Nucala for COPD

The relentless cycle of flare-ups for those with severe Chronic Obstructive Pulmonary Disease has long demanded a more precise therapeutic weapon, a need the UK's health authorities have now addressed with a new approval. This review evaluates Nucala (mepolizumab), recently authorized by the MHRA

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later